Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 397 to 402 of 402 entries
Sorted by: Best Match Show Resources per page
Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital.

Cancers

Wong YNS, Sng CCT, Ottaviani D, Patel G, Chowdhury A, Earnshaw I, Sinclair A, Merry E, Wu A, Galazi M, Benafif S, Soosaipillai G, Chopra N, Roylance R, Shaw H, Lee AJX.
PMID: 34885194
Cancers (Basel). 2021 Dec 02;13(23). doi: 10.3390/cancers13236085.

An increased mortality risk was observed in patients with cancer during the first wave of COVID-19. Here, we describe determinants of mortality in patients with solid cancer comparing the first and second waves of COVID-19. A retrospective analysis encompassing...

Cite
Wong YNS, Sng CCT, Ottaviani D, et al. Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital. Cancers (Basel). 2021;13(23)doi: 10.3390/cancers13236085.
Wong, Y. N. S., Sng, C. C. T., Ottaviani, D., Patel, G., Chowdhury, A., Earnshaw, I., Sinclair, A., Merry, E., Wu, A., Galazi, M., Benafif, S., Soosaipillai, G., Chopra, N., Roylance, R., Shaw, H., & Lee, A. J. X. (2021). Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital. Cancers, 13(23), . https://doi.org/10.3390/cancers13236085
Wong, Yien Ning Sophia, et al. "Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital." Cancers vol. 13,23 (2021). doi: https://doi.org/10.3390/cancers13236085
Wong YNS, Sng CCT, Ottaviani D, Patel G, Chowdhury A, Earnshaw I, Sinclair A, Merry E, Wu A, Galazi M, Benafif S, Soosaipillai G, Chopra N, Roylance R, Shaw H, Lee AJX. Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital. Cancers (Basel). 2021 Dec 02;13(23). doi: 10.3390/cancers13236085. PMID: 34885194; PMCID: PMC8657102.
Copy Download .nbib Format: NLM
Application of a simple unstructured kinetic and cost of goods models to support T-cell therapy manufacture.

Biotechnology progress

Shariatzadeh M, Lopes AG, Glen KE, Sinclair A, Thomas RJ.
PMID: 34455707
Biotechnol Prog. 2021 Nov;37(6):e3205. doi: 10.1002/btpr.3205. Epub 2021 Sep 14.

Manufacturing of cell therapy products requires sufficient understanding of the cell culture variables and associated mechanisms for adequate control and risk analysis. The aim of this study was to apply an unstructured ordinary differential equation-based model for prediction of...

Cite
Shariatzadeh M, Lopes AG, Glen KE, et al. Application of a simple unstructured kinetic and cost of goods models to support T-cell therapy manufacture. Biotechnol Prog. 2021;37(6):e3205doi: 10.1002/btpr.3205.
Shariatzadeh, M., Lopes, A. G., Glen, K. E., Sinclair, A., & Thomas, R. J. (2021). Application of a simple unstructured kinetic and cost of goods models to support T-cell therapy manufacture. Biotechnology progress, 37(6), e3205. https://doi.org/10.1002/btpr.3205
Shariatzadeh, Maryam, et al. "Application of a simple unstructured kinetic and cost of goods models to support T-cell therapy manufacture." Biotechnology progress vol. 37,6 (2021): e3205. doi: https://doi.org/10.1002/btpr.3205
Shariatzadeh M, Lopes AG, Glen KE, Sinclair A, Thomas RJ. Application of a simple unstructured kinetic and cost of goods models to support T-cell therapy manufacture. Biotechnol Prog. 2021 Nov;37(6):e3205. doi: 10.1002/btpr.3205. Epub 2021 Sep 14. PMID: 34455707.
Copy Download .nbib Format: NLM
First Inventory of Access and Quality of Metabolic Surgery Across Europe.

Obesity surgery

Sinclair P, Vijgen GHEJ, Aarts EO, Van Nieuwenhove Y, Maleckas A.
PMID: 34508296
Obes Surg. 2021 Dec;31(12):5196-5206. doi: 10.1007/s11695-021-05633-1. Epub 2021 Sep 10.

INTRODUCTION: Europe consists of 51 independent countries. Variation in healthcare regulations results in differing challenges faced by patients and professionals. This study aimed to gain more insight into the accessibility, patient pathway and quality indicators of metabolic and body...

Cite
Sinclair P, Vijgen GHEJ, Aarts EO, et al. First Inventory of Access and Quality of Metabolic Surgery Across Europe. Obes Surg. 2021;31(12):5196-5206doi: 10.1007/s11695-021-05633-1.
Sinclair, P., Vijgen, G. H. E. J., Aarts, E. O., Van Nieuwenhove, Y., & Maleckas, A. (2021). First Inventory of Access and Quality of Metabolic Surgery Across Europe. Obesity surgery, 31(12), 5196-5206. https://doi.org/10.1007/s11695-021-05633-1
Sinclair, Piriyah, et al. "First Inventory of Access and Quality of Metabolic Surgery Across Europe." Obesity surgery vol. 31,12 (2021): 5196-5206. doi: https://doi.org/10.1007/s11695-021-05633-1
Sinclair P, Vijgen GHEJ, Aarts EO, Van Nieuwenhove Y, Maleckas A. First Inventory of Access and Quality of Metabolic Surgery Across Europe. Obes Surg. 2021 Dec;31(12):5196-5206. doi: 10.1007/s11695-021-05633-1. Epub 2021 Sep 10. PMID: 34508296; PMCID: PMC8595173.
Copy Download .nbib Format: NLM
Current Perspective on Retinal Migraine.

Vision (Basel, Switzerland)

Chong YJ, Mollan SP, Logeswaran A, Sinclair AB, Wakerley BR.
PMID: 34449754
Vision (Basel). 2021 Aug 23;5(3). doi: 10.3390/vision5030038.

Retinal migraine was first formally described in 1882. Various terms such as "ocular migraine" and "ophthalmic migraine" have since been used interchangeably in the literature. The lack of a consistent consensus-based definition has led to controversy and potential confusion...

Cite
Chong YJ, Mollan SP, Logeswaran A, et al. Current Perspective on Retinal Migraine. Vision (Basel). 2021;5(3)doi: 10.3390/vision5030038.
Chong, Y. J., Mollan, S. P., Logeswaran, A., Sinclair, A. B., & Wakerley, B. R. (2021). Current Perspective on Retinal Migraine. Vision (Basel, Switzerland), 5(3), . https://doi.org/10.3390/vision5030038
Chong, Yu Jeat, et al. "Current Perspective on Retinal Migraine." Vision (Basel, Switzerland) vol. 5,3 (2021). doi: https://doi.org/10.3390/vision5030038
Chong YJ, Mollan SP, Logeswaran A, Sinclair AB, Wakerley BR. Current Perspective on Retinal Migraine. Vision (Basel). 2021 Aug 23;5(3). doi: 10.3390/vision5030038. PMID: 34449754; PMCID: PMC8396291.
Copy Download .nbib Format: NLM
Global Hand: Time to Capacity Build.

World journal of plastic surgery

Kadhum M, Sinclair P, Khundkar R.
PMID: 33330016
World J Plast Surg. 2020 Sep;9(3):349-350. doi: 10.29252/wjps.9.3.349.

No abstract available.

Cite
Kadhum M, Sinclair P, Khundkar R. Global Hand: Time to Capacity Build. World J Plast Surg. 2020;9(3):349-350doi: 10.29252/wjps.9.3.349.
Kadhum, M., Sinclair, P., & Khundkar, R. (2020). Global Hand: Time to Capacity Build. World journal of plastic surgery, 9(3), 349-350. https://doi.org/10.29252/wjps.9.3.349
Kadhum, Murtaza, et al. "Global Hand: Time to Capacity Build." World journal of plastic surgery vol. 9,3 (2020): 349-350. doi: https://doi.org/10.29252/wjps.9.3.349
Kadhum M, Sinclair P, Khundkar R. Global Hand: Time to Capacity Build. World J Plast Surg. 2020 Sep;9(3):349-350. doi: 10.29252/wjps.9.3.349. PMID: 33330016; PMCID: PMC7734944.
Copy Download .nbib Format: NLM
Application of a simple unstructured kinetic and cost of goods models to support T-cell therapy manufacture.

Biotechnology progress

Shariatzadeh M, Lopes AG, Glen KE, Sinclair A, Thomas RJ.
PMID: 34455707
Biotechnol Prog. 2021 Aug 28;e3205. doi: 10.1002/btpr.3205. Epub 2021 Aug 28.

Manufacturing of cell therapy products requires sufficient understanding of the cell culture variables and associated mechanisms for adequate control and risk analysis. The aim of this study was to apply an unstructured ordinary differential equation-based model for prediction of...

Cite
Shariatzadeh M, Lopes AG, Glen KE, et al. Application of a simple unstructured kinetic and cost of goods models to support T-cell therapy manufacture. Biotechnol Prog. 2021;e3205doi: 10.1002/btpr.3205.
Shariatzadeh, M., Lopes, A. G., Glen, K. E., Sinclair, A., & Thomas, R. J. (2021). Application of a simple unstructured kinetic and cost of goods models to support T-cell therapy manufacture. Biotechnology progress, e3205. https://doi.org/10.1002/btpr.3205
Shariatzadeh, Maryam, et al. "Application of a simple unstructured kinetic and cost of goods models to support T-cell therapy manufacture." Biotechnology progress vol. (2021): e3205. doi: https://doi.org/10.1002/btpr.3205
Shariatzadeh M, Lopes AG, Glen KE, Sinclair A, Thomas RJ. Application of a simple unstructured kinetic and cost of goods models to support T-cell therapy manufacture. Biotechnol Prog. 2021 Aug 28;e3205. doi: 10.1002/btpr.3205. Epub 2021 Aug 28. PMID: 34455707.
Copy Download .nbib Format: NLM
Showing 397 to 402 of 402 entries